Purroy N et al. Dose-adjusted EPOCH plus rituximab in untreated patients with poor prognosis large B-cell, with analysis of germinal center and activated B-cell biomarkers. A Phase IV study conducted by the Spanish PETHEMA group. Proc ASH 2011;Abstract 593.

Dr Moskowitz is Clinical Director in the Division of Hematologic Oncology at Memorial Sloan-Kettering Cancer Center and Professor of Medicine at Weill Medical College of Cornell University in New York, New York.

Dr O'Connor is Professor of Medicine and Developmental Therapeutics and Director of the Center for Lymphoid Malignancies at Columbia University Medical Center in New York, New York.